Amsterdam UMC-backed national INFECT-TT programme launched: ready to invests 7 million in accelerated clinical product development for infectious diseases.
Amplio Pharma B.V. recently completed a second closing within their Seed Investment Round in support of the clinical development of NovoBioJect for the treatment of rheumatoid arthritis
